Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminophylline for Acute Exacerbation of COPD
ChiCTR-IPR-16007879Phase 4Not yet recruiting
- Sponsor
- Guangzhou First People's Hospital
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Aminophylline intravenous with Placebo intravenous (2 arms). Primary endpoints: Length of stay in hospital and COPD Assessment Test (CAT) score. Planned start Feb 2016; status: not yet recruiting.
02
Drugs
aminophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-IPR-16007879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16007879.